QFTA vs. DMAQ, HAIA, JMAC, RWOD, ATAK, EFHT, MCAE, WWAC, OLIT, and SELX
Should you be buying Quantum FinTech Acquisition stock or one of its competitors? The main competitors of Quantum FinTech Acquisition include Deep Medicine Acquisition (DMAQ), Healthcare AI Acquisition (HAIA), Maxpro Capital Acquisition (JMAC), Redwoods Acquisition (RWOD), Aurora Technology Acquisition (ATAK), EF Hutton Acquisition Co. I (EFHT), Mountain Crest Acquisition Corp. III (MCAE), Worldwide Webb Acquisition (WWAC), OmniLit Acquisition (OLIT), and Semilux International (SELX). These companies are all part of the "holding & other investment offices" industry.
Quantum FinTech Acquisition (NYSE:QFTA) and Deep Medicine Acquisition (NASDAQ:DMAQ) are both small-cap unclassified companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, community ranking, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.
Deep Medicine Acquisition's return on equity of 0.00% beat Quantum FinTech Acquisition's return on equity.
30.5% of Quantum FinTech Acquisition shares are owned by institutional investors. Comparatively, 18.4% of Deep Medicine Acquisition shares are owned by institutional investors. 2.4% of Quantum FinTech Acquisition shares are owned by company insiders. Comparatively, 1.7% of Deep Medicine Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Quantum FinTech Acquisition and Deep Medicine Acquisition both received 0 outperform votes by MarketBeat users.
In the previous week, Quantum FinTech Acquisition's average media sentiment score of 0.00 equaled Deep Medicine Acquisition'saverage media sentiment score.
Quantum FinTech Acquisition has a beta of -0.3, suggesting that its stock price is 130% less volatile than the S&P 500. Comparatively, Deep Medicine Acquisition has a beta of 0.02, suggesting that its stock price is 98% less volatile than the S&P 500.
Summary
Quantum FinTech Acquisition beats Deep Medicine Acquisition on 3 of the 5 factors compared between the two stocks.
Get Quantum FinTech Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for QFTA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding QFTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quantum FinTech Acquisition Competitors List
Related Companies and Tools
